Basics Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $3.13B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 2.55% Avg Daily Range (30 D): $0.74 | 2.18% Avg Daily Range (90 D): $0.64 | 2.54% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 1.64M Avg Daily Volume (90 D): 1.75M Trade Size Avg Trade Size (Sh.): 82 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 3,538 Avg Inst. Trade: $2.07M Avg Inst. Trade (30 D): $2.62M Avg Inst. Trade (90 D): $2.43M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.01M Avg Closing Trade (30 D): $5.96M Avg Closing Trade (90 D): $5.04M Avg Closing Volume: 173.09K     News Nov 21, 2025 @ 2:00 PM American Kidney Fund Hosts Third Patient Access In... Source: Lavarne A. Burton Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer Mar 17, 2025 @ 11:01 AM Travere Therapeutics Submits sNDA to FDA for Appro... Source: N/A Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.29 $-.14 $-.47 Diluted EPS $.28 $-.14 $-.47 Revenue $ 164.86M $ 114.45M $ 81.73M Gross Profit $ 163.27M $ 112.93M $ 77.05M Net Income / Loss $ 25.71M $ -12.76M $ -41.23M Operating Income / Loss $ 24.93M $ -12.65M $ -42.67M Cost of Revenue $ 1.59M $ 1.52M $ 4.68M Net Cash Flow $ 35.78M $ 13.26M $ 3.36M PE Ratio 124.46     Splits Nov 08, 2011:   1:9